Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that new
data from multiple studies of asfotase alfa in pediatric patients with
hypophosphatasia (HPP) will be presented at the American Society for
Bone and Mineral Research (ASBMR) 2014 Annual Meeting, which takes place
September 12-15, 2014 in Houston, Texas.
for Researchers to Present New Data on Asfotase Alfa in Pediatric Patients with Hypophosphatasia at the American Society for Bone and Mineral Research 2014 Annual Meeting investment picks